Nyrada Inc. (ASX:NYR)
Australia · Delayed Price · Currency is AUD 1.150
-0.220 (-16.06%)
At close: Jan 9, 2026
Nyrada Market Cap
Nyrada has a market cap or net worth of 280.12 million as of January 9, 2026. Its market cap has increased by 1,168.38% in one year.
Market Cap
280.12M
Enterprise Value
277.19M
Revenue
2.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.15
Market Cap Chart
Since January 16, 2020, Nyrada's market cap has increased from 25.71M to 280.12M, an increase of 989.75%. That is a compound annual growth rate of 49.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 333.71M | 22.48% |
| Dec 31, 2025 | 272.45M | 1,278.00% |
| Dec 31, 2024 | 19.77M | 476.06% |
| Dec 29, 2023 | 3.43M | -84.83% |
| Dec 30, 2022 | 22.62M | -39.58% |
| Dec 31, 2021 | 37.44M | 42.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 81.96B |
| Pro Medicus | 22.46B |
| Cochlear | 17.17B |
| Sonic Healthcare | 10.94B |
| Ramsay Health Care | 8.20B |
| Ansell | 5.07B |
| Telix Pharmaceuticals | 3.73B |
| Mesoblast | 3.50B |